{"id":87898,"date":"2023-11-15T12:39:56","date_gmt":"2023-11-15T07:09:56","guid":{"rendered":"http:\/\/finservwealth.com\/gland-pharma-gets-tentative-usfda-nod-for-blood-pressure-medication\/"},"modified":"2023-11-15T12:39:56","modified_gmt":"2023-11-15T07:09:56","slug":"gland-pharma-gets-tentative-usfda-nod-for-blood-pressure-medication","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/gland-pharma-gets-tentative-usfda-nod-for-blood-pressure-medication\/","title":{"rendered":"Gland Pharma gets tentative USFDA nod for blood pressure medication"},"content":{"rendered":"<p> Gland Pharma believes that it is the only company with first to file for this product and may be eligible for 180 days of generic drug exclusivity.<\/p><div id=\"finse-398831258\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/gland-pharma-gets-tentative-usfda-nod-for-blood-pressure-medication_17329371.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Gland Pharma believes that it is the only company with first to file for this product and may be eligible for 180 days of generic drug exclusivity. Gland Pharma believes that it is the only company with first to file for this product and may be eligible for 180 days of generic drug exclusivity.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/business\/gland-pharma-gets-tentative-usfda-nod-for-blood-pressure-medication_17329371.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> Gland Pharma believes that it is the only company with first to file for this product and may be eligible for 180 days of generic drug exclusivity.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/gland-pharma-gets-tentative-usfda-nod-for-blood-pressure-medication_17329371.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Gland Pharma believes that it is the only company with first to file for this product and may be eligible for 180 days of generic drug exclusivity. Gland Pharma believes that it is the only company with first to file for this product and may be eligible for 180 days of generic drug exclusivity.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/business\/gland-pharma-gets-tentative-usfda-nod-for-blood-pressure-medication_17329371.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> Gland Pharma believes that it is the only company with first to file for this product and may be eligible for 180 days of generic drug exclusivity.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-87898","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2021\/200x200\/G\/Gland-Pharma_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/87898","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=87898"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/87898\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=87898"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=87898"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=87898"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}